AKRON BIOTECH
History
| Year | Detail |
|---|---|
| 2006 | Founded by Claudia Zylberberg, PhD, in 2006, Akron is a materials manufacturer and services provider to the regenerative medicine industry, accelerating the development and commercialization of advanced therapies. |
| 2018 | Akron Biotechnology partnered with Marsha Rolle, an associate professor of biomedical engineering at Worcester Polytechnic Institute (WPI), to develop a novel cryopreservation media for storing and transporting manufactured tissues. |
| 2020 | Akron Biotech partnered with Cytiva to implement the FlexFactory platform for manufacturing Plasmid DNA, a critical component in many innovative therapies and vaccines. |
| 2022 | The company collaborated with Vor Bio, a clinical-stage cell and genome engineering company, on the development and cGMP manufacture of nucleases to strengthen Akron’s portfolio of off-the-shelf gene editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies. |
| 2023 | Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs, partnered with Akron Bio to automate and standardize the use of cytokines in cell therapy manufacturing. |
BCC Research Beacon 